Premium NMN 30,000 mg, 120 capsules: profile, composition and research

Reference page for Premium NMN 30,000 mg, 120 capsules. Active substance: Никотинамидмононуклеотид (NMN) / Nicotinamide mononucleotide (NMN).

Key facts

What nicotinamide mononucleotide is

Nicotinamide mononucleotide (NMN) is a naturally occurring nucleotide from which the body builds the coenzyme NAD+ (nicotinamide adenine dinucleotide). The molecule combines nicotinamide, ribose and a phosphate group, which places it among the ribonucleotides. Small amounts of NMN are present in living cells as an intermediate of metabolism.

NAD+ takes part in hundreds of metabolic reactions. Inside a cell it acts as an electron carrier in oxidation-reduction processes and as a substrate for enzymes that regulate energy balance and DNA repair. When the coenzyme runs short, those processes slow down and the cell copes less well with stress.

The amount of NAD+ in tissues falls with age, and that observation underlies the interest in supplements supplying precursors of the coenzyme. NMN is one such precursor, alongside nicotinamide riboside and nicotinamide. The routes by which cells turn them into NAD+ are studied in laboratory and clinical work.

A capsule of this product provides 250 mg of NMN together with additional ingredients: PQQ, resveratrol, coenzyme Q10 and euglena extract. It is a food supplement rather than a medicine: it has no medical indications and does not replace treatment prescribed by a doctor.

How NMN relates to NAD+ turnover

Once swallowed, NMN reaches the bloodstream, and the literature discusses more than one possible route for it afterwards: part of the molecule may be converted into other NAD+ precursors before it enters a cell. Transport across cell membranes is still under study, and no single picture has been settled.

Within the cell NAD+ has two central roles. It serves as a coenzyme in reactions that release energy, and it is also a substrate for the sirtuin and PARP families of enzymes, which take part in the response to DNA damage and in the regulation of gene activity.

When NAD+ is consumed in those reactions the pool has to be refilled, or the activity of the enzymes that depend on it declines. Precursors such as NMN are studied precisely for their part in replenishing the pool and keeping its level in tissues. That is why the topic attracts research attention.

Status and intended use

The manufacturer presents the product as a food supplement intended to support everyday wellbeing. A supplement has no medicinal indications and is not meant to diagnose, treat or prevent any disease. That distinction matters when choosing products for health.

Because it is an addition to the diet rather than a medicine, the product does not replace balanced nutrition or treatment prescribed by a doctor. Decisions about supplements are discussed with a clinician, particularly when a chronic condition is present or other products are used.

The amount and the manner of intake are stated by the manufacturer on the pack; for a supplement that is a limit, not a recommendation from a reference article. How long it is taken is a matter for a doctor or a nutrition specialist, who weighs the expected benefit against possible risks.

What the research shows

Clinical work on NMN remains fairly limited and involves small groups of participants. In some studies of middle-aged adults, laboratory markers changed, including a rise in blood NAD+ levels after a course of the supplement. The studies are still short in duration.

Other trials examined the supplement's effect on insulin sensitivity in women with prediabetes, on aerobic capacity in amateur runners, and on sleep quality and fatigue in older people. Findings vary, and reproducibility is still limited. Larger and longer trials are still awaited.

Part of the literature addresses tolerability and safety: no serious adverse events were described in the groups observed. Large long-term trials with clinical endpoints remain scarce, so conclusions about health effects stay preliminary. That is why the findings are described as early.

Published research

Primary sources, verified against PubMed:

• The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial., PubMed 36482258 (GeroScience, 2023).
• Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women., PubMed 33888596 (Science (New York, N.Y.), 2021).
• Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study., PubMed 34238308 (Journal of the International Society of Sports Nutrition, 2021).
• Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women., PubMed 36002548 (Scientific reports, 2022).

Listed for reference. Publication of a study is not a claim about this particular product.

Precautions

• This is a food supplement, not a medicine: it has no indications for treating disease.
• A supplement does not replace balanced nutrition or treatment prescribed by a doctor.
• Discuss the supplement with a clinician before starting it, particularly with a chronic condition or other medicines in use.
• In pregnancy, when planning pregnancy or while breastfeeding, intake is agreed with a doctor.
• Sensitive individuals may notice digestive discomfort, headache or changes in sleep.
• Do not exceed the amount stated by the manufacturer on the pack.
• Keep the pack tightly closed in a cool, dry place, out of the reach of children.

Frequently asked